Quest Diagnostics Aktie
WKN: 904533 / ISIN: US74834L1008
|
21.10.2025 12:54:21
|
Quest Diagnostics Q3 Income Climbs
(RTTNews) - Quest Diagnostics (DGX) announced a profit for its third quarter that Increases, from last year
The company's bottom line totaled $245 million, or $2.16 per share. This compares with $226 million, or $1.99 per share, last year.
Excluding items, Quest Diagnostics reported adjusted earnings of $296 million or $2.60 per share for the period.
The company's revenue for the period rose 13.2% to $2.816 billion from $2.488 billion last year.
Quest Diagnostics earnings at a glance (GAAP) :
-Earnings: $245 Mln. vs. $226 Mln. last year. -EPS: $2.16 vs. $1.99 last year. -Revenue: $2.816 Bln vs. $2.488 Bln last year.
-Guidance: Full year EPS guidance: $9.76 - $9.84 Full year revenue guidance: $10.96 - $11.00 Bln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
| Quest Diagnostics Inc. | 153,95 | -0,29% |
|